These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT). Vindeløv L Eur J Haematol; 2001 Feb; 66(2):73-82. PubMed ID: 11168513 [TBL] [Abstract][Full Text] [Related]
4. How best to analyse new strategies in bone marrow transplantation. Gale RP; Horowitz MM Bone Marrow Transplant; 1990 Dec; 6(6):357-9. PubMed ID: 2097005 [No Abstract] [Full Text] [Related]
5. New strategies for BMT and organ transplantation. Ikehara S Int J Hematol; 2002 Aug; 76 Suppl 1():161-4. PubMed ID: 12430846 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation in the United Kingdom - past, present and future. Barrett J; Craddock C Br J Haematol; 2020 Nov; 191(4):612-616. PubMed ID: 33190255 [TBL] [Abstract][Full Text] [Related]
7. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Majhail NS; Farnia SH; Carpenter PA; Champlin RE; Crawford S; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Savani BN; Veys PA; Bredeson CN; Giralt SA; LeMaistre CF Biol Blood Marrow Transplant; 2015 Nov; 21(11):1863-1869. PubMed ID: 26256941 [TBL] [Abstract][Full Text] [Related]
9. New strategies for BMT, organ transplantation, and regeneration therapy. Ikehara S Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656 [TBL] [Abstract][Full Text] [Related]
10. Hematopoietic growth factors in bone marrow transplantation. Mertelsmann R; Herrmann F; Hecht T; Schulz G Bone Marrow Transplant; 1990 Aug; 6(2):73-7. PubMed ID: 1698494 [TBL] [Abstract][Full Text] [Related]
11. A unifying strategy for clinical trials in rare urological malignancy. Nicholson S Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645 [No Abstract] [Full Text] [Related]
12. [Methodology and management of clinical trials with small number of patients for rare diseases]. Micallef J Presse Med; 2012 May; 41 Suppl 1():S32-4. PubMed ID: 22483773 [No Abstract] [Full Text] [Related]
13. Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities. Krishnan ML; Berry-Kravis E; Capal JK; Carpenter R; Gringras P; Hipp JF; Miller MT; Mingorance A; Philpot BD; Pletcher MT; Rotenberg A; Tjeertes J; Wang PP; Willgoss T; de Wit MC; Jeste SS Nat Rev Drug Discov; 2021 Sep; 20(9):653-654. PubMed ID: 34002058 [No Abstract] [Full Text] [Related]
14. Treatment of autoimmune diseases in mice by a new method for allogeneic bone marrow transplantation. Ikehara S Ther Apher Dial; 2003 Jun; 7(3):292-7. PubMed ID: 12924603 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts. Ebens CL; McGrath JA; Tamai K; Hovnanian A; Wagner JE; Riddle MJ; Keene DR; DeFor TE; Tryon R; Chen M; Woodley DT; Hook K; Tolar J Br J Dermatol; 2019 Dec; 181(6):1238-1246. PubMed ID: 30843184 [TBL] [Abstract][Full Text] [Related]
16. The promise and challenges of rare cancer research. Komatsubara KM; Carvajal RD Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336 [No Abstract] [Full Text] [Related]
17. A new bone marrow transplantation method for stem cell disorders. Ikehara S Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228 [TBL] [Abstract][Full Text] [Related]
18. A network of patients with orphan retinal diseases for clinical trials: goals, structure, challenges. Weleber RG Retina; 2005 Dec; 25(8 Suppl):S66-S67. PubMed ID: 16374344 [No Abstract] [Full Text] [Related]